Moyamoya Disease
What's New
Last Posted: Apr 16, 2024
- Association of Genetic Variants with Postoperative Donor Artery Development in Moyamoya Disease: RNF213 and Other Moyamoya Angiopathy-Related Gene Analysis.
Seiei Torazawa, et al. Translational stroke research 2024 0 - Association between polymorphism in the MTHFR gene and encephaloduroarteriosynangiosis-induced collateral circulation formation.
Gan Gao, et al. Journal of neurosurgery 2024 0 1-9 - RNF213 variant and autophagic impairment: A pivotal link to endothelial dysfunction in moyamoya disease.
Hee Sun Shin, et al. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2024 0 271678X241245557 - RNF213 in moyamoya disease: Genotype-phenotype association and the underlying mechanism.
Jianxun Fang, et al. Chinese medical journal 2024 0 - Neuregulin 1 as a potential biomarker for disease progression in moyamoya disease: A case-control study in Chinese population.
Jie Chen, et al. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2024 0 (3) 107581 - Posterior cerebral artery involvement in unilateral moyamoya disease is exclusively ipsilateral and influenced by RNF213 mutation gene dose: The SUPRA Japan study: PCA involvement in unilateral moyamoya.
Yohei Mineharu, et al. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2023 0 (2) 107513 - Synergistic Interaction of Thyroid Autoantibodies and Ring Finger Protein 213 Variant in Moyamoya Disease.
Thiparpa Thamamongood, et al. Neurologia medico-chirurgica 2023 0 - De novo variants in RNF213 are associated with a clinical spectrum ranging from Leigh syndrome to early-onset stroke.
Theresa Brunet, et al. Genetics in medicine : official journal of the American College of Medical Genetics 2023 0 101013 - Difference in Clinical Phenotype, Mutation Position, and Structural Change of RNF213 Rare Variants Between Pediatric and Adult Japanese Patients with Moyamoya Disease.
Shunsuke Nomura, et al. Translational stroke research 2023 0 - Hypertensive disorders of pregnancy in moyamoya disease: A single institution experience.
Hirohisa Yajima, et al. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2023 0 (11) 107377 - Association of thyroid peroxidase antibody with the RNF213 p.R4810K variant in ischemic stroke/transient ischemic attack.
Takeshi Yoshimoto, et al. Atherosclerosis 2023 0 117281 - Amplified Risk of Intracranial Artery Stenosis/Occlusion Associated With RNF213 p.R4810K in Familial Hypercholesterolemia.
Kotaro Noda, et al. JACC. Asia 2023 0 (4) 625-633 - Neurological comorbidities and novel mutations in Turkish cases with neurofibromatosis type 1.
Evlice Ahmet, et al. Ideggyogyaszati szemle 2023 0 (7-8) 270-274 - Association between DIAPH1 variant and posterior circulation involvement with Moyamoya disease.
Shihao He, et al. Scientific reports 2023 0 (1) 10732 - Whole-exome sequencing in moyamoya patients of Northern-European origin identifies gene variants involved in Nitric Oxide metabolism: A pilot study.
Markus K H Wiedmann, et al. Brain & spine 2023 0 101745 - Genome-wide association study identifies novel susceptibilities to adult moyamoya disease.
Jin Pyeong Jeon, et al. Journal of human genetics 2023 0 - Meta-analysis of the association between RNF213 polymorphisms and clinical features of moyamoya disease in Asian population.
Xiaolong Jiang, et al. Clinical neurology and neurosurgery 2023 0 107801 - RNF213 p.Arg4810Lys Wild Type is Associated with De Novo Hemorrhage in Asymptomatic Hemispheres with Moyamoya Disease.
Seiei Torazawa, et al. Translational stroke research 2023 0 - Rare variants in ANO1, encoding a calcium-activated chloride channel, predispose to moyamoya disease.
Amélie Pinard, et al. Brain : a journal of neurology 2023 0 - Association of RNF213 polymorphism and cortical hyperintensity sign on fluid-attenuated inversion recovery images after revascularization surgery for moyamoya disease: Correspondence.
Amnuay Kleebayoon, et al. Neurosurgical review 2023 0 (1) 126 - Association of RNF213 polymorphism and cortical hyperintensity sign on fluid-attenuated inversion recovery images after revascularization surgery for moyamoya disease: possible involvement of intrinsic vascular vulnerability.
Haruto Uchino, et al. Neurosurgical review 2023 0 (1) 119 - A long-term study of posterior circulation changes after revascularization in patients with moyamoya disease.
Bao Xiang-Yang, et al. Journal of neurosurgery 2023 0 1-6 - Association of rare RNF213 variants and intracranial aneurysm risk in a Chinese population.
Li Yaqi, et al. Annals of translational medicine 2023 0 (24) 1336 - Circulating Inflammatory Cytokine Associated with Poor Prognosis in Moyamoya Disease: A Prospective Cohort Study.
Liu Wei, et al. Journal of clinical medicine 2023 0 (3) - Clinical and Genetic Characteristics of Patients with Moyamoya Disease who Experienced Both Ischemic and Hemorrhagic Events.
Hirano Yudai, et al. World neurosurgery 2023 0 - Cav-1 (Caveolin-1) and Arterial Remodeling in Adult Moyamoya Disease.
Chung Jong-Won, et al. Stroke 2018 0 (11) 2597-2604 - Can Moyamoya Disease Susceptibility Gene Affect Extracranial Systemic Artery Stenosis?
Nomura Shunsuke, et al. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2019 0 (2) 104532 - Postoperative Symptomatic Cerebral Infarction in Pediatric Moyamoya Disease: Risk Factors and Clinical Outcome.
Choi Jung Won, et al. World neurosurgery 2019 0 e158-e164 - Association Between p.R4810K Variant and Long-Term Clinical Outcome in Patients With Moyamoya Disease.
Ge Peicong, et al. Frontiers in neurology 2019 0 662 - Poor outcomes in carriers of the RNF213 variant (p.Arg4810Lys) with pulmonary arterial hypertension.
Hiraide Takahiro, et al. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2019 0 (2) 103-112
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Page last updated:May 03, 2024
- Content source: